Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
ALTAMONTE SPRINGS, Fla., Sept. 28, 2017 -- Approved by the U.S. FDA in 2005, the Class IV K-Laser utilizes pre-determined wavelengths of near-infrared and red light to increase circulation and decrease pain, swelling and inflammation indicative of neuropathies. Following a series of successful clinical trials, the FDA further cleared K-Laser therapy for facilitating repair and regeneration of damaged tissue due to the laser's ability to draw nutrients, oxygen and water into inflamed soft tissues. Proponents of K-Laser therapy Drs. Danielle and Roy Clarke of Beyond Chiropractic in Altamonte Springs, FL have been successfully using K-Laser technology as an alternative to surgery and pain medications when treating symptoms of neuropathy, specifically diabetic neuropathy and chemo-related neuropathy.
Neuropathy Response to K-Laser Therapy
Disorders of the nervous system and/or nerve damage may cause neuropathic pain, a type of burning, shooting pain often severe and chronic. Diabetic neuropathy arises when high blood glucose levels erode the integrity of nerves and blood vessels. People receiving chemotherapy may also suffer peripheral neuropathy when taking powerful, anti-carcinogenic medications. Although chemotherapy is essential for eradicating cancer cells and tumors, it can have a medically negative affect on nerves connecting the spinal cord to organs, skin and muscles.
A type of biomodifying laser energy, K-Laser increases cellular metabolic activity while improving transport of nutrients in and out of a cell's membrane. By triggering production of ATP (a chemical necessary for cell health), K-Laser works to relieve nerve inflammation, reduce neuropathic pain and facilitate blood flow throughout the affected area. In addition, ongoing clinical research shows the K-Laser to be a safe and effective therapeutic modality treatment for diabetic neuropathy, chemotherapy-related neuropathy and many other chronic pain conditions such as arthritis, bursitis, Bell's Palsy and plantar fasciitis.
Drs. Danielle and Roy Clarke of Beyond Chiropractic offer K-Laser therapy for treating nervous and musculoskeletal disorders. Located at 460 E Altamonte Dr. in Altamonte Springs, FL, Beyond Chiropractic can be reached by calling 407-261-1001.
